Der Orthopäde

, Volume 38, Issue 9, pp 812–817

Therapie der postoperativen Thrombose

Leitthema
  • 115 Downloads

Zusammenfassung

Neben der frühzeitigen Diagnose einer postoperativen Beinvenenthrombose ist eine sofortige, suffiziente Therapie notwendig, um die Manifestation einer Lungenembolie zu vermeiden, eine Rezidivthrombose zu verhindern und der Entwicklung des postthrombotischen Syndroms vorzubeugen. Bei der praktischen Umsetzung eines strukturierten Thrombosetherapieregimes bestehen oft noch Unklarheiten. In der folgenden Übersicht werden therapeutische Optionen in Abhängigkeit von individuellen expositionellen und dispositionellen Risiken vor dem Hintergrund evidenzbasierter Daten und Empfehlungen der Fachgesellschaften dargestellt.

Schlüsselwörter

Venöse Thromboembolie Thrombosebehandlung Orthopädie Unfallchirurgie Leitlinien 

Treatment of postoperative thrombosis

Abstract

For the treatment of deep vein thrombosis (DVT), rapid diagnosis and prompt therapy are crucial to minimize the risk of fatal pulmonary embolism and long-term complications, including the postthrombotic syndrome and recurrent thromboembolism. The treatment of acute DVT remains controversial. In this review, treatment options in relation to exposing and predisposing risk factors are discussed. Evidence-based data and recommendations from official guidelines are presented.

Keywords

Venous thromboembolism Treatment of thrombosis Orthopedic surgery Trauma surgery Guidelines 

Literatur

  1. 1.
    Arcasoy SM, Vachani A (2003) Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 24:73–91PubMedCrossRefGoogle Scholar
  2. 2.
    Arepally GM, Ortel TL (2006) Heparin-induced thrombocytopenia. N Engl J Med 355:809–817PubMedCrossRefGoogle Scholar
  3. 3.
    Aschwanden M, Labs KH, Engel H (2001) Acute deep vein thrombosis: early mobilisation does not increase the frequency of pulmonary embolism. Thromb Haemost 85:42–46PubMedGoogle Scholar
  4. 4.
    Brandjes DPM, Büller HR, Heijboer H (1997) Randomized trial of effect of compression stockings in patients with symptomatik proximal-vein thrombosis. Lancet 349:759–762PubMedCrossRefGoogle Scholar
  5. 5.
    Büller HR, Davidson BL, Decousus H (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. Ann Intern Med 140:867–873PubMedGoogle Scholar
  6. 6.
    Büller HR, Agnelli HR, Hull RD (2004) Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapie. Chest 126:401–428CrossRefGoogle Scholar
  7. 7.
    Decousus H, Leizorovicz A, Parent F (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d‚Embolie Pulmonaire par interruption Cave Study Group. N Engl J Med 338:409–415PubMedCrossRefGoogle Scholar
  8. 8.
    DGA: Interdisziplinäre S2-Leitlinie (2005) Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungeembolie. VASA 34(Suppl):66CrossRefGoogle Scholar
  9. 9.
    Erikson H, Wahlander K, Gustafsson D (2003) A randomized, controlled, doseguiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I. J Thromb Haemost 1:41–47CrossRefGoogle Scholar
  10. 10.
    Gulba DC, Schmidt C, Borst HG (1994) Medical compared with surgical tratment for massive pulmonary embolism. Lancet 343:576–577PubMedCrossRefGoogle Scholar
  11. 11.
    Hach W (Hrsg) (2007) VenenChirurgie. Schattauer, Stuttgart, S 206–212Google Scholar
  12. 12.
    Hirsch J, Dalen JE, Anderson DR (2001) Oral anticoagulans: Mechanism of action, clinical effectiveness and optimal therapeutid range. Chest 119:8–21CrossRefGoogle Scholar
  13. 13.
    Hutten BA, Prins MH (2004) Duration of treatment with Vitamin K antagonists in symptomatic venous thromboembolism (Cochrane Review). The Chochrane Library: Issue 4Google Scholar
  14. 14.
    Iorio A, Guercini F, Pini M (2002) Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: metha analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 1:1906–1913CrossRefGoogle Scholar
  15. 15.
    Kasper W, Konstantinides S, Geibel A (1997) Prognostic significans of right ventricular afterload stress detected by echocardiography in patients with clinically susspected pulmonary embolism. Heart 77:346–349PubMedGoogle Scholar
  16. 16.
    Kearon C (2003) Natural history of venous thromboembolism. Circulation 107:I22–I30PubMedGoogle Scholar
  17. 17.
    Konstantinides S, Geibel A, Olschewski M (2002) Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263–1268PubMedCrossRefGoogle Scholar
  18. 18.
    Koopmann MMW, Prandoni P, Piovella F (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcoutaneous low-molecular-weight heparin administered at home. N Engl J Med 334:682–687CrossRefGoogle Scholar
  19. 19.
    Kurkciyan II, Sterz F, Meron G (2000) Thrombolysis and pulmonary embolism presenting with cardiac arrest. Arch Intern Med 160:3496–3497CrossRefGoogle Scholar
  20. 20.
    Lagerstedt CL, Olsson CG, Fagher BO (1985) Need for long-term anticoagulant tratment in symptomatic calf-vein thrombosis. Lancet 2:515–518PubMedCrossRefGoogle Scholar
  21. 21.
    Levine M, Gent M, Hirsch J (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677–681PubMedCrossRefGoogle Scholar
  22. 22.
    Linke LC, Katthagen BD (1999) Weight-based heparin dosing is more effective in the treatment of Postoperative deep vein thrombosis. Arch Orthop Trauma Surg 208–211Google Scholar
  23. 23.
    Linke LC, Katthagen BD (1999) Gewichtsadaptierte Heparintherapie zur Behandlung venöser Thrombosen in der Gelenkchirurgie. Unfallchirurgie 193–197Google Scholar
  24. 24.
    Mills TD, Chan O, Matson M (2001) The use of vena caval filters. J Hosp Med 62:327–331Google Scholar
  25. 25.
    Partsch H, Blätter W (2000) Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 32:861–869PubMedCrossRefGoogle Scholar
  26. 26.
    Pengo V, Lensing AW, Prins MH (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264PubMedCrossRefGoogle Scholar
  27. 27.
    Pinede L, Duhaut P, Cucherat M (2000) Comparison of long versus short duration of antikoagulant therapie after a first episode of venous thromboembolism: a metha-analysis of randomized, controlled trials. J Intern Med 247:553–562PubMedCrossRefGoogle Scholar
  28. 28.
    Prandoni P, Lensing AW, Bernadi E (2002) The diagnostic value of compression ultrasonographie in patients with susspected recurrent deep vein thrombosis. Thromb Haemost 88:402–406PubMedGoogle Scholar
  29. 29.
    Prandoni P, Lensing AW, Prins MH (2004) Below knee elastic compression stockings to prevent the posttrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141:249–256PubMedGoogle Scholar
  30. 30.
    Quinlan DJ, McQuillan A, Eikelboom JW (2004) Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a metha-analysis of randomized, controlled trials. Ann Intern Med 140:175–183PubMedGoogle Scholar
  31. 31.
    Ridker PM, Goldhaber SZ, Danielson E (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromoembolism. N Engl J Med 348:1425–1434PubMedCrossRefGoogle Scholar
  32. 32.
    Schellong SM, Schwarz T, Kropp J (1999) Bed rest in deep vein thrombosis and the incidence of scinigraphic pulmonary embolism. Thromb Haemost 82:127–129PubMedGoogle Scholar
  33. 33.
    Schulman S, Wahlander K, Lundström T (2003) Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 349:1713–1721PubMedCrossRefGoogle Scholar
  34. 34.
    Schulman S (1985) Studies of the medical treatment of deep venous thrombosis. Acta Med Scand Suppl 704:46–47Google Scholar
  35. 35.
    Segal JB, Streiff MB, Hofmann LV (2007) Management of venous thromboembolism: A systematic review for a practice guidline. Ann Intern Med 146:211–222PubMedGoogle Scholar
  36. 36.
    Simmoneau G, Sors H, Charbonnier B (1997) A comparison of low-molecular- weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337:663–669CrossRefGoogle Scholar
  37. 37.
    Stiegler H, Sunder-Plasmann L (1987) Akute Verschlüsse der Venen (untere und obere Extremität) In: Heberer G, van Dongen RJAM (Hrsg) Gefäßchirurgie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  38. 38.
    Stiegler H, Tosch U, Sunder-Plasmann L (1985) Venöse Thrombektomie iliofemoraler Venenthrombosen. Münch Med Wochenschr 127:84–87Google Scholar
  39. 39.
    The Matisse Investigators (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349:1695–1702CrossRefGoogle Scholar
  40. 40.
    van den Belt AG, Prins MH, Lensing AW (2000) Fixed dose subcutaneus low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboebolism. Cochrane Database Syst Rev CD001100Google Scholar
  41. 41.
    van Dongen CJ, Vink R, Hutten BA (2003) The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time scince first event: a metha analysis. Arch Intern Med 163:1285–1293CrossRefGoogle Scholar
  42. 42.
    van der Heijden JF, Hutten BA, Büller HR (2000) Vitamin K antagonists or lowmolecular- weight heparin fort he long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev (4):CD002001 2002Google Scholar
  43. 43.
    Warkentin TE, Maurer BT, Aster RH (2007) Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 356(25):2653–2654PubMedCrossRefGoogle Scholar
  44. 44.
    Warkentin TE, Greinacher A, Koster A, Lincoff AM (2008) Treatment and prevention of heparin induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(Suppl):340–380CrossRefGoogle Scholar
  45. 45.
    White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:4–8CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2009

Authors and Affiliations

  1. 1.Klinik für Orthopädie und spezielle Orthopädische ChirurgieKlinikum Vest, Standort Paracelsus-KlinikMarlDeutschland

Personalised recommendations